This study is for people living with HIV whose treatment is already keeping the virus under control. Researchers are testing whether switching to new medicines, bictegravir and lenacapavir (together in one pill), is as safe and effective as continuing current HIV treatment. The goal is to see if this new option could make treatment simpler while still keeping HIV suppressed.
